Literature DB >> 15535985

Functional analysis of human microsomal epoxide hydrolase genetic variants.

Vinayak P Hosagrahara1, Allan E Rettie, Christopher Hassett, Curtis J Omiecinski.   

Abstract

Human microsomal epoxide hydrolase (EPHX1) is active in the metabolism of many potentially carcinogenic or otherwise genotoxic epoxides, such as those derived from the oxidation of polyaromatic hydrocarbons. EPHX1 is polymorphic and encodes allelic variation at least two amino acid positions, Y113H and H139R. In a number of recent molecular epidemiological investigations, EPHX1 polymorphism has been suggested as a susceptibility factor for several human diseases. To better evaluate the functional contribution of EPHX1 genetic polymorphism, we characterized the enzymatic properties associated with each of the respective variant proteins. Enzymatic profiles were evaluated with cis-stilbene oxide (cSO) and benzo[a]pyrene-4,5-epoxide (BaPO), two prototypical substrates for the hydrolase. In one series of experiments, activities of recombinant EPHX1 proteins were analyzed subsequent to their expression using the pFastbac baculovirus vector in Spodoptera frugiperda-9 (Sf9) insect cells, and purification by column chromatography. In parallel studies, EPHX1 activities were evaluated with human liver microsomes derived from individuals of known EPHX1 genotype. Using the purified protein preparations, rates of cSO and BaPO hydrolysis for the reference protein, Y113/H139, were approximately 2-fold greater than those measured with the other EPHX1 allelic variants. However, when activities were analyzed using human liver microsomal fractions, no major differences were evident in the reaction rates generated among preparations representing the different EPHX1 alleles. Collectively, these results suggest that the structural differences encoded by the Y113H and H139R variant alleles exert only modest impact on EPHX1-specific enzymatic activities in vivo.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15535985      PMCID: PMC4091877          DOI: 10.1016/j.cbi.2004.07.004

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  50 in total

1.  Role of genetic polymorphism of glutathione-S-transferase T1 and microsomal epoxide hydrolase in aflatoxin-associated hepatocellular carcinoma.

Authors:  E W Tiemersma; R E Omer; A Bunschoten; P van't Veer; F J Kok; M O Idris; A M Kadaru; S S Fedail; E Kampman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2001-07       Impact factor: 4.254

2.  Enhanced proteasomal degradation of mutant human thiopurine S-methyltransferase (TPMT) in mammalian cells: mechanism for TPMT protein deficiency inherited by TPMT*2, TPMT*3A, TPMT*3B or TPMT*3C.

Authors:  H L Tai; M Y Fessing; E J Bonten; Y Yanishevsky; A d'Azzo; E Y Krynetski; W E Evans
Journal:  Pharmacogenetics       Date:  1999-10

3.  Gene evolution of epoxide hydrolases and recommended nomenclature.

Authors:  J K Beetham; D Grant; M Arand; J Garbarino; T Kiyosue; F Pinot; F Oesch; W R Belknap; K Shinozaki; B D Hammock
Journal:  DNA Cell Biol       Date:  1995-01       Impact factor: 3.311

4.  The functional expression of sodium-dependent bile acid transport in Madin-Darby canine kidney cells transfected with the cDNA for microsomal epoxide hydrolase.

Authors:  P von Dippe; M Amoui; R H Stellwagen; D Levy
Journal:  J Biol Chem       Date:  1996-07-26       Impact factor: 5.157

5.  Identification and functional characterization of human soluble epoxide hydrolase genetic polymorphisms.

Authors:  M Sandberg; C Hassett; E T Adman; J Meijer; C J Omiecinski
Journal:  J Biol Chem       Date:  2000-09-15       Impact factor: 5.157

6.  Induction of rat liver microsomal epoxide hydrolase by its endogenous substrate 16 alpha, 17 alpha-epoxyestra-1,3,5-trien-3-ol.

Authors:  F Fändrich; B Degiuli; U Vogel-Bindel; M Arand; F Oesch
Journal:  Xenobiotica       Date:  1995-03       Impact factor: 1.908

7.  Assignment1 of microsomal epoxide hydrolase (EPHX1) to human chromosome 1q42.1 by in situ hybridization.

Authors:  J K Hartsfield; M J Sutcliffe; E T Everett; C Hassett; C J Omiecinski; J A Saari
Journal:  Cytogenet Cell Genet       Date:  1998

8.  Hydration of arene and alkene oxides by epoxide hydrase in human liver microsomes.

Authors:  J Kapitulnik; W Levin; R Morecki; P M Dansette; D M Jerina; A H Conney
Journal:  Clin Pharmacol Ther       Date:  1977-02       Impact factor: 6.875

9.  Association of CYP1A1 and microsomal epoxide hydrolase polymorphisms with lung squamous cell carcinoma.

Authors:  P Lin; S L Wang; H J Wang; K W Chen; H S Lee; K J Tsai; C Y Chen; H Lee
Journal:  Br J Cancer       Date:  2000-02       Impact factor: 7.640

10.  Association of microsomal epoxide hydrolase polymorphisms and lung cancer risk.

Authors:  A Gsur; T Zidek; K Schnattinger; E Feik; G Haidinger; P Hollaus; A Mohn-Staudner; C Armbruster; S Madersbacher; G Schatzl; K Trieb; C Vutuc; M Micksche
Journal:  Br J Cancer       Date:  2003-08-18       Impact factor: 7.640

View more
  12 in total

Review 1.  System review and metaanalysis of the relationships between five metabolic gene polymorphisms and colorectal adenoma risk.

Authors:  Zhi-Qiang Zhao; Qing-Kai Guan; Fei-Yun Yang; Peng Zhao; Bing Zhou; Zhi-Jun Chen
Journal:  Tumour Biol       Date:  2011-12-13

2.  In Vitro Metabolism of Oprozomib, an Oral Proteasome Inhibitor: Role of Epoxide Hydrolases and Cytochrome P450s.

Authors:  Zhican Wang; Ying Fang; Juli Teague; Hansen Wong; Christophe Morisseau; Bruce D Hammock; Dan A Rock; Zhengping Wang
Journal:  Drug Metab Dispos       Date:  2017-04-20       Impact factor: 3.922

3.  Genetic variants in antioxidant genes are associated with diisocyanate-induced asthma.

Authors:  Berran Yucesoy; Victor J Johnson; Zana L Lummus; Grace E Kissling; Kara Fluharty; Denyse Gautrin; Jean-Luc Malo; André Cartier; Louis-Philippe Boulet; Joaquin Sastre; Santiago Quirce; Dori R Germolec; Susan M Tarlo; Maria-Jesus Cruz; Xavier Munoz; Michael I Luster; David I Bernstein
Journal:  Toxicol Sci       Date:  2012-05-17       Impact factor: 4.849

4.  High fat diet induced obesity alters ovarian phosphatidylinositol-3 kinase signaling gene expression.

Authors:  J Nteeba; J W Ross; J W Perfield; A F Keating
Journal:  Reprod Toxicol       Date:  2013-08-14       Impact factor: 3.143

5.  Genetic association analysis of functional impairment in chronic obstructive pulmonary disease.

Authors:  Craig P Hersh; Dawn L Demeo; Ross Lazarus; Juan C Celedón; Benjamin A Raby; Joshua O Benditt; Gerard Criner; Barry Make; Fernando J Martinez; Paul D Scanlon; Frank C Sciurba; James P Utz; John J Reilly; Edwin K Silverman
Journal:  Am J Respir Crit Care Med       Date:  2006-02-02       Impact factor: 21.405

6.  Microsomal epoxide hydrolase, glutathione S-transferase P1, traffic and childhood asthma.

Authors:  Muhammad T Salam; Pi-Chu Lin; Edward L Avol; W James Gauderman; Frank D Gilliland
Journal:  Thorax       Date:  2007-08-21       Impact factor: 9.139

Review 7.  Microsomal epoxide hydrolase 1 (EPHX1): Gene, structure, function, and role in human disease.

Authors:  Radka Václavíková; David J Hughes; Pavel Souček
Journal:  Gene       Date:  2015-07-26       Impact factor: 3.688

8.  Associations between smoking, polymorphisms in polycyclic aromatic hydrocarbon (PAH) metabolism and conjugation genes and PAH-DNA adducts in prostate tumors differ by race.

Authors:  Nora L Nock; Deliang Tang; Andrew Rundle; Christine Neslund-Dudas; Adnan T Savera; Cathryn H Bock; Kristin G Monaghan; Allison Koprowski; Nicoleta Mitrache; James J Yang; Benjamin A Rybicki
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-06       Impact factor: 4.254

Review 9.  The genetics of chronic obstructive pulmonary disease.

Authors:  Alice M Wood; Robert A Stockley
Journal:  Respir Res       Date:  2006-10-20

10.  Biomarkers of human exposure to acrylamide and relation to polymorphisms in metabolizing genes.

Authors:  Nur Duale; Thomas Bjellaas; Jan Alexander; Georg Becher; Margaretha Haugen; Jan Erik Paulsen; Henrik Frandsen; Pelle Thonning Olesen; Gunnar Brunborg
Journal:  Toxicol Sci       Date:  2009-01-08       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.